All News Medical Marijuana, Inc.

Equities

MJNA

US58463A1051

Delayed OTC Markets Other stock markets 02:01:16 2024-04-29 pm EDT			5-day change	1st Jan Change
0.0019 ^USD	-5.00%		-5.00%	-48.65%

2023	AXIM Biotechnologies, Inc. announced that it expects to receive $0.75 million in funding from Medical Marijuana, Inc.	CI
2023	Medical Marijuana, Inc. acquired Essentially all Operating Assets of KZ1 for $5 million.	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Thinking about buying stock in Inpixon, Medical Marijuana, Hello Group, Vroom, or Heritage Insurance Holdings?	Mar. 15	PR
AXIM Biotechnologies, Inc. announced that it expects to receive $0.75 million in funding from Medical Marijuana, Inc.	Dec. 25	CI
Medical Marijuana, Inc. acquired Essentially all Operating Assets of KZ1 for $5 million.	23-07-31	CI
Medical Marijuana, Inc. Announces Executive Changes	23-03-14	CI
Medical Marijuana, Inc. Appoints Dr. Timothy R. Scott as Its New Chief Executive Officer	23-03-14	CI
Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion	23-03-14	AQ
Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries	23-02-06	AQ
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point	23-01-24	AQ
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology	22-11-29	AQ
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results	22-11-22	AQ
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets	22-11-01	AQ
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia	22-10-20	AQ
Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment	22-10-12	AQ
Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President	22-10-04	AQ
Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region	22-09-08	AQ
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results	22-08-18	AQ
Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil	22-08-11	AQ
GRN Holdings Corporation, Inc. (OTC: GRNF) Announces Name Change to Marijuana Inc., New Management and Business Model	22-08-05	AQ
Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News	22-07-26	AQ
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Health & Wellness Podcast; Secures Features in Top Brazil Lifestyle Publications	22-07-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Medical Marijuana, Inc.

Equities

MJNA

US58463A1051

All News

Filters